Fundraising Fox

DarioHealth

NASDAQ: DRIO

New York, US · Founded 2011 · Delaware corporation · 248 employees on LinkedIn · 2 known investors

Dario provides digital tools and support to help people manage chronic conditions such as diabetes between provider visits. Its platform focuses on day-to-day health management for individuals with one or more chronic conditions, primarily in the U.S.

BiotechDigital HealthHealthtechMental HealthWellness & Fitness

Founders & leadership

ERErez Raphael
Erez RaphaelChief Executive Officer
ZB
Zvi Ben DavidChief Financial Officer, Treasurer, and Secretary
SN
Steven NelsonChief Commercial Officer
AS
Adam SternNamed on SEC filing
DM
Dennis McGrathNamed on SEC filing
OF
Oren Fuerst, PhDNamed on SEC filing
DW
David Weintraub, MDNamed on SEC filing
GL
Gadi LevinNamed on SEC filing

Board

AK
Adam K. SternBoard director
HKHila Karah
Hila KarahinMember Board of DirectorsManaging Partner | HealthTech at Pitango
PK
Peter KashBoard director
YS
Yoav ShakedChairman of the Board

Investors · 2

Agate Medical Investments LPTel-Aviv
PitangoreportedTel Aviv · $4M – $100Mvia Hila Karah · board

Reported raises · per SEC filings

Form D private placements

$282.3M disclosed across 19 rounds · 2014–2025

▶$17.5MraisedOct 2025 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence LeisureDirector
  • Dennis MatheisDirector
  • Steven NelsonExecutive Officer
  • Dennis M. McGrathDirector
  • Adam K. SternDirector
  • Yoav ShakedDirector
  • Erez RaphaelExecutive Officer
  • Chen Franco-YehudaExecutive Officer, Director
  • Hila KarahDirector
Offering amount
$17.5M
Amount sold
$17.5M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.8MraisedJan 2025 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yoav ShakedDirector
  • Erez RaphaelExecutive Officer, Director
  • Zvi Ben DavidExecutive Officer
  • Adam K. SternDirector
  • Jon KaplanDirector
  • Dennis MatheisDirector
  • Dennis M. McGrathDirector
  • Steven NelsonExecutive Officer
  • Hila KarahDirector
Offering amount
$6.8M
Amount sold
$6.8M
Minimum investment
$1K
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.8MraisedJan 2025 · 29 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yoav ShakedDirector
  • Adam K. SternDirector
  • Zvi Ben DavidExecutive Officer
  • Dennis MatheisDirector
  • Steven NelsonExecutive Officer
  • Erez RaphaelExecutive Officer, Director
  • Hila KarahDirector
  • Dennis M. McGrathDirector
  • Jon KaplanDirector
Offering amount
$18.8M
Amount sold
$18.8M
Minimum investment
$1K
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.4MraisedFeb 2024 · 119 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Raphael ErezExecutive Officer, Director
  • Dennis M. McGrathDirector
  • Yoav ShakedExecutive Officer
  • Zvi Ben-DavidExecutive Officer
  • Richard AndersonExecutive Officer
  • Adam SternDirector
  • Jon KaplanDirector
  • Hila KarahDirector
  • Dennis MatheisDirector
Offering amount
$22.4M
Amount sold
$22.4M
Sales commissions
$1.4M
Placement agents
Aegis Capital Corp.
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.4MraisedMay 2023 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard AndersonExecutive Officer
  • Zvi Ben-DavidExecutive Officer
  • Raphael ErezExecutive Officer, Director
  • Dennis M. McGrathDirector
  • Dennis MatthesisDirector
  • Adam SternDirector
  • Jon KaplanDirector
  • Hila KarahDirector
  • Yoav ShakedExecutive Officer
Offering amount
$15.4M
Amount sold
$15.4M
Finders' fees
$410K
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$24MraisedJun 2021 · 74 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Erez RaphaelExecutive Officer, Director
  • Dennis MatheisDirector
  • Yoav ShakedDirector
  • Dror BacherExecutive Officer
  • Dennis M. McGrathDirector
  • Hila KarahDirector
  • Zvi Ben-DavidExecutive Officer
  • Richard B StoneDirector
  • Richard AndersonExecutive Officer
  • Adam SternDirector
Offering amount
$24M
Amount sold
$24M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31MraisedFeb 2021 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hila KarahDirector
  • Dennis MatheisDirector
  • Adam SternDirector
  • Yoav ShakedDirector
  • Richard AndersonExecutive Officer
  • Oded CohenExecutive Officer
  • Dror BacherExecutive Officer
  • Erez RaphaelExecutive Officer, Director
  • Zvi Ben-DavidExecutive Officer
  • Richard B StoneDirector
  • Adam SternDirector
  • Dennis M. McGrathDirector
Offering amount
$31M
Amount sold
$31M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$70MraisedFeb 2021 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Erez RaphaelExecutive Officer, Director
  • Zvi Ben-DavidExecutive Officer
  • Dror BacherExecutive Officer
  • Richard AndersonExecutive Officer
  • Yoav ShakedDirector
  • Richard B StoneDirector
  • Dennis MatheisDirector
  • Hila KarahDirector
  • Adam SternDirector
  • Dennis M. McGrathDirector
  • Adam SternDirector
Offering amount
$70M
Amount sold
$70M
Minimum investment
$100K
Sales commissions
$4.9M
Placement agents
Stifel, Nicolaus & Company, Incorporated, SternAegis Ventures, Cowen and Company, LLC
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Diabetes1217 shared keywordsThe American Diabetes Association is a nonprofit organization focused on diabetes prevention, research, advocacy, and education, providing resources, community programs, and support for people living with diabetes and prediabetes in the United States. It also advocates for policy such as affordable insulin and hosts scientific and technology conferences.

Companies competing with DarioHealth for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does DarioHealth do?
Dario provides digital tools and support to help people manage chronic conditions such as diabetes between provider visits. Its platform focuses on day-to-day health management for individuals with one or more chronic conditions, primarily in the U.S.
Who are DarioHealth's investors?
DarioHealth's investors include Agate Medical Investments LP, Pitango.
How much funding has DarioHealth raised?
DarioHealth has disclosed $282.3M raised across 19 rounds.
Where is DarioHealth headquartered?
DarioHealth is headquartered in New York, US.